Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - PharMerica CORP | Financial_Report.xls |
| EX-32.2 - EXHIBIT 32.2 - PharMerica CORP | ex32_2.htm |
| EX-10.26 - EXHIBIT 10.26 - PharMerica CORP | ex10_26.htm |
| EX-31.1 - EXHIBIT 31.1 - PharMerica CORP | ex31_1.htm |
| EX-10.27 - EXHIBIT 10.27 - PharMerica CORP | ex10_27.htm |
| EX-10.25 - EXHIBIT 10.25 - PharMerica CORP | ex10_25.htm |
| EX-31.2 - EXHIBIT 31.2 - PharMerica CORP | ex31_2.htm |
| 10-Q - PHARMERICA CORPORATION 10-Q 3-31-2015 - PharMerica CORP | form10q.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of PharMerica Corporation (the "Corporation") on Form 10-Q for the quarter ended March 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Gregory S. Weishar, Chief Executive Officer and Director of the Corporation, certify, pursuant to18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.
| /s/ Gregory S. Weishar | |
|
Gregory S. Weishar
|
|
|
Chief Executive Officer and Director
|
|
|
May 7, 2015
|